共 72 条
[1]
Peny JM(2005)Financial requirements of immunisation programmes in developing countries: a 2004–2014 perspective Vaccine 23 4610-4618
[2]
Gleizis O(1999)Safety and immunogenicity of hepatitis B vaccine ButaNG in adults Rev Inst Med Trop Sao Paulo 41 191-193
[3]
Covilard JP(2003)Estudo multicêntrico de imonogenicidade e reatogenicidade de vacinas contra hepatite B: informe preliminar Epidemiologia e Serviços de Saúde 12 165-166
[4]
Ioshimoto LM(2006)Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang vaccine in adolescents from low income families in Central Brazil Mem Inst Oswaldo Cruz 101 251-256
[5]
Rissato ML(2006)Efetividade das vacinas anti-VHB (DNA-recombinante) em doadores de sangue de uma região endêmica para hepatite B no sul do Brasil Rev Soc Bras Med Trop 39 462-426
[6]
Bonilha VSJ(2001)Residual transfusion risk for hepatitis B and C in southern Brazil, 1991–99 J Viral Hepat 8 78-82
[7]
Miyaki C(2004)Transfusion risk for hepatitis B, hepatitis C and HIV in the state of Santa Catarina, Brazil, 1991–2001 Braz J Infect Dis 8 236-240
[8]
Raw I(2005)Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil Transfusion 45 1709-1714
[9]
Granovski N(1996)The risk of transfusion-transmitted viral infections New Eng J Med 334 1685-1690
[10]
Martins RM(2003)Seroprevalence of HBsAg, Anti-HBc and anti-HCV in Southern Brazil, 1999–2001 Braz J Infect Dis 7 262-267